Anika Therapeutics Inc. · NASDAQ:ANIK

Anika Therapeutics — Sidoti Small Cap Investor Conference (September 2023)

16 slides from Anika Therapeutics's conference presentation, Sep 21, 2023

  1. Slide 1: Investor Overview - Sidoti Small Cap Investor Conference

    Anika. Restore Active Living. ΠSIDOTI SMALL CAP INVESTOR CONFERENCE INVESTOR OVERVIEW SEPTEMBER 21, 2023

  2. Slide 2: Safe Harbor Statements

    Safe Harbor Statements 2 Cautionary Note on Forward - looking Statements The statements made in, and during the course of, this presentation that are not statements of historical fact, including those related to the Company’s commercial capabilities, initiatives and production, its product pipeline

  3. Slide 3: Anika: A Well-Positioned Company With A Compelling Future

    6+ NEW PRODUCT LAUNCHES in Fastest Growing Segments of Joint Preservation SIGNIFICANT & ONGOING CASH FLOW GENERATION STRONG HYALURONIC ACID (HA) FRANCHISE Leading osteoarthritis (OA) pain management franchise with Monovisc® and Orthovisc® and Cingal® OUS Newly launched products are expected to gener

  4. Slide 4: Multiple New Product Launches in Fast Growing Joint Preservation Markets

    Multiple New Product Launches in Fast Growing Joint Preservation Markets to Accelerate Growth 63% 32% 5% 90% 2% 8% REVENUE GROWTH & DIVERSIFICATION $115M $156M 2019 2022 In 2023 and early 2024, we are launching innovative products in the largest and fastest growing markets that compete with existing

  5. Slide 5: Successful Full Market Launch in 2023 of X-Twist Fixation System

    Versatile Suture Eyelet Strong Fixation Open Design Supports Healing Fast and Easy to Insert (X - Spline Ρ ) Successful Full Market Launch in 2023 of X - Twist Ρ Fixation System X - Twist Fixation System is a feature - rich suture anchor platform for soft tissue repairs in the shoulder and other ext

  6. Slide 6: RevoMotion Reverse Shoulder System Moves to Full Market Launch

    Bone Preserving Design Smallest Diameter Threaded Baseplate Personalized Options Anatomic Mid - Lay Humeral Enhanced Facility Efficiency Two Instrument Tray Design Limited Market Launch of RevoMotion Ρ Reverse Shoulder Arthroplasty System Moves to Full Market Launch in September 2023 So far, early i

  7. Slide 7: Integrity Regenerative Rotator Cuff Patch System Launches Q1-2024

    Strong Hybrid*, multifilament structure provides superior implant handling and strength vs. collagen - based products Versatile Differentiated lateral - to - medial fixation and technique via tacks and darts, provides confidence across continuum of tears Proven Higher regenerative capacity vs. first

  8. Slide 8: Integrity Patch System Highly Differentiated Compared to Collagen Patches

    Integrity Ρ Patch System Highly Differentiated Compared to Collagen Patches Greater mechanical integrity for easier insertion Greater regenerative capacity of HA - based patch vs. collagen through 26 weeks 1 Histology showing greater regenerative capacity with Integrity vs. collagen INTEGRITY 8 COMP

  9. Slide 9: Advancing Hyalofast and Cingal Towards FDA Approval

    Advancing Hyalofast® and Cingal® Towards FDA Approval Expecting final PMA module filing with FDA in 2025 for Hyalofast US Launch in 2026 • Single - stage, off - the - shelf, resorbable, HA - based scaffold for cartilage repair • Provides entry into $1 billion U.S. knee cartilage repair market • Rece

  10. Slide 10: Driving Commercial Focus While Actively Managing Costs

    Driving Commercial Focus While Actively Managing Costs to Enhance Margins and Profitability Actively managing OpEx spend, while preparing to support significant growth in coming years • Significant progress in both launching breakthrough products and addressing Medical Device Regulations (MDR) enabl

  11. Slide 11: Key Value Drivers

    Key Value Drivers RevoMotion fully launched in September 2023 on very positive surgeon feedback from limited release Executing market launch of Integrity in Q1 - 2024 expanding opportunities in fast growing rotator cuff augmentation market Driving double - digit joint preservation growth with new la

  12. Slide 12: Appendix

    a Appendix

  13. Slide 13: Highly Differentiated Pipeline Solves Unmet Needs in Early Intervention Orthopedics

    HIGHLY DIFFERENTIATED PIPELINE SOLVES UNMET NEEDS IN EARLY INTERVENTION ORTHOPEDICS $3B+ MARKET OPPORTUNITY OPENED BY SUCCESSIVE PRODUCT LAUNCH CADENCE Note: Last Patient Out (LPO) 1 SmartTRAK 2023 and internal estimates 2 Overall timing is unknown, largely dependent upon nonclinical testing plan an

  14. Slide 14: Anika's Solutions Across the Orthopedic Continuum of Care

    Joint Preservation Pre - treatment, Conservative Treatment Traditional Total Joint Replacements OVO ® & OVOMotion ® Tactoset ® SpeedSpiral ® CMC PF Wave ® / WaveKahuna ® Hyalofast ® (OUS) Total WristMotion ® Monovisc ® Orthovisc ® Cingal ® (OUS) Synd - EZ Œ Syndesmosis 1 st Metatarsal (Hemi & Total)

  15. Slide 15: Expanding Market Opportunity in Joint Preservation

    EXPANDING MARKET OPPORTUNITY IN JOINT PRESERVATION 1 Combination of iData, SmartTRAK, and internal estimates; 2 SmartTRAK and Anika internal estimates. CAGR 2021 - 2026 3 Received 510(k) clearance from FDA in Q3 - 2023; planned launch in Q1 - 2024 Extremities >$4B HA/Visco >$1B Regen >$1B Soft Tissu

  16. Slide 16: Seasoned Leadership Team Driving Growth Strategy

    SEASONED LEADERSHIP TEAM DRIVING GROWTH STRATEGY DECADES OF EXPERIENCE LEADING ORTHOPEDIC, REGENERATIVE MEDICINE, AND MEDICAL DEVICE COMPANIES Mike Levitz EVP, CFO & Treasurer 2020 David Colleran EVP, General Counsel & Corporate Secretary 2020 James Chase SVP, International Sales & Marketing 2018 Da

Anika Therapeutics — Sidoti Small Cap Investor Conference (September 2023) on 6ix